Summary Judgment of Earn-out Litigation for Change Healthcare

We obtained summary judgment on behalf of Change Healthcare and related entities in federal court litigation in Seattle stemming from Change Healthcare’s acquisition of a start-up business in the healthcare technology industry where the stock purchase agreement had contingent earn-out provisions. The former shareholders of the start-up business alleged, among other claims, breach of the implied covenant of good faith and fair dealing and breach of contract under Delaware law. Representative matters include: Lilly v. Envoy, LLC, No. C15-0742RSM, 2016 WL 7375271 (W.D. Wash. Dec. 20, 2016). 

Change Healthcare (formerly NYSE: EM) is a leading provider of software and analytics, network solutions and technology-enabled services that optimize communications, payments and actionable insights designed to enable smarter healthcare.

You Also May Be Interested In:

  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee

    We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company
  • Bass, Berry & Sims served as lead counsel to Tennessee Orthopedic Alliance (TOA) in obtaining a Certificate of Need (CON)...
    Client Type: Private Company